SCHEMBL29740761

SCHEMBL29740761

COc1cccc(-c2ccccc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.64
▸ CYP1A2 P05177 1/20 0.64
▸ CYP2E1 P05181 1/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ CYP2C8 P10632 1/20 0.64
▸ CYP2D6 P10635 1/20 0.64
▸ CYP2A6 P11509 1/20 0.64
▸ CYP2C9 P11712 1/20 0.64
▸ CYP4B1 P13584 1/20 0.64
▸ CYP2B6 P20813 1/20 0.64
▸ CYP3A5 P20815 1/20 0.64
▸ CYP2A7 P20853 1/20 0.64
▸ CYP3A7 P24462 1/20 0.64
▸ CYP2F1 P24903 1/20 0.64
▸ CYP2C18 P33260 1/20 0.64
▸ CYP2C19 P33261 1/20 0.64
▸ CYP2J2 P51589 1/20 0.64
▸ CYP4F2 P78329 1/20 0.64
▸ CYP4F8 P98187 1/20 0.64
▸ CYP4A11 Q02928 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458391 1.00 CYP1A1 (0.64) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL13247865 0.98 ABL1 (0.64) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL28102064 0.96 CYP1A2 (0.72) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Methylamine SCHEMBL27666960 0.96 MAOB (0.61) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Methyl Alcohol SCHEMBL28369741 0.96 HDAC4 (0.59) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Hydrochloric Acid SCHEMBL28963139 0.96 CYP1A2 (0.59) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Methane SCHEMBL28582279 0.96 CYP1A2 (0.59) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Formaldehyde SCHEMBL21629200 0.94 HDAC4 (0.58) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
Cyanide SCHEMBL27973193 0.94 CYP1A2 (0.57) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL1180343 0.93 ABL1 (0.69) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361238-A1 1,4-DIPHENYL-1H-INDAZOLE AND 1-PYRIDIN-2-YL-4-PHENYL-1H-INDAZOLE DERIVATIVES AS PD-1/PD-L1 MODULATORS FOR THE TREATMENT OF CANCER SOPONPONG JAKAPUN (TH) 2025-11-27 — — US disclosed
US-20240336601-A1 4-PHENYL-INDOLE DERIVATIVES AND RELATED USES CHULALONG UNIVERSITY (TH) 2024-10-10 — — US disclosed
CN-115784848-A Nor-sorbosone derivative and preparation method and application thereof 成都理工大学 2023-03-14 — — CN disclosed
CN-115448957-A Novel tetradentate platinum complexes 通用显示公司 2022-12-09 — — CN disclosed
CN-110249442-B Compound (I) 学校法人关西学院 2022-11-22 — — CN disclosed
CN-111732611-B Novel tetradentate platinum complexes 通用显示公司 2022-08-23 — — CN disclosed
CN-113652705-B Method for synthesizing fluorenone through catalytic electrolysis of N-hydroxyphthalimide 北京工业大学 2022-07-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361238-A1 1,4-DIPHENYL-1H-INDAZOLE AND 1-PYRIDIN-2-YL-4-PHENYL-1H-INDAZOLE DERIVATIVES AS PD-1/PD-L1 MODULATORS FOR THE TREATMENT OF CANCER PDCD1, CD274, PDCD1LG2 CYP1A1 49/4885CYP1A2 244/4885CYP2E1 81/4885
US-20240336601-A1 4-PHENYL-INDOLE DERIVATIVES AND RELATED USES PDCD1, PDCD1LG2, CD274 CYP1A1 108/4885CYP1A2 294/4885CYP2E1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback